Seelos Therapeutics Doses First Patient in a Registrational Phase II/III study of SLS-005 in Spinocerebellar Ataxia Psychedelics Investing
Goodness Growth Holdings Commences Litigation Against Verano for unlawful termination of Arrangement Agreement Psychedelics Investing
Silo Wellness Announces LOI for Potentially Largest Psilocybin Retreat Center in Oregon and the World - If November's Election Is Favorable; and an Oregon Real Estate Law and Psilocybin Industry Primer Psychedelics Investing
Albert Labs Files New International PCT Patent Application for scalable API manufacturing Pharmaceutical Investing
Trip to Treatment: Lobe Sciences CEO Touts Targeted Low Dosing for Better Patient Outcomes Pharmaceutical Investing
Silo Wellness Closes Acquisition of Dyscovry Science and Its Psilocybin Pharmaceutical Biosynthesis and Research Portfolio Psychedelics Investing
Lobe Sciences Announces the Completion of cGMP Production of Clinical Supplies For Upcoming Clinical Trials Pharmaceutical Investing
COMPASS Pathways Announces Phase 3 Pivotal Program Design for COMP360 in Treatment Resistant Depression at Capital Markets Day Psychedelics Investing
Silo Wellness Adds Biotech Research Expertise to its Psychedelic Wellness Portfolio Psychedelics Investing
